DeepNewz, mobile.

People-sourced. AI-powered. Unbiased News.

Screenshot of DeepNewz app showing story detail view.

Screenshot of DeepNewz app showing story list view.

Viking Therapeutics News

Madrigal Pharmaceuticals Nears $400 After EU Approval of MASH Drug, 450% Return Since 2022, Baker Brothers Buying Shares

Madrigal Pharmaceuticals Nears $400 After EU Approval of MASH Drug, 450% Return Since 2022, Baker Brothers Buying Shares

6

4 months ago

Viking Therapeutics Drops 41% on Mixed Phase 2 Obesity Pill Data

Viking Therapeutics Drops 41% on Mixed Phase 2 Obesity Pill Data

42

4 months ago

Latest stories

Aug 19, 2025
Aug 19, 2025
Stocks
Pharma
Business
Viking Therapeutics Drops 41% on Mixed Phase 2 Obesity Pill Data
Authors
42
4 months ago
Aug 18, 2025
Aug 18, 2025
Stocks
Pharma
Business
Madrigal Pharmaceuticals Nears $400 After EU Approval of MASH Drug, 450% Return Since 2022, Baker Brothers Buying Shares
Authors
6
4 months ago

Join our channels

Get the latest stories live on any device.

WhatsApp
Top Stories
Join
Telegram
Top Stories
Join